Vylor, Inc., an advanced seed and genetics company, announced it will release its third quarter 2026 earnings on November 11, 2026, after the stock market closes. The company will host a live webcast presentation of the earnings on November 12 at 9:00 a.m. Eastern Time, with slides available on its Investor Events page. A replay of the webcast will be accessible for one year. This earnings report is important as it reflects Vylor's ongoing innovation and growth in agricultural biotechnology, impacting farmers and shareholders globally.
Vylor's upcoming third quarter 2026 earnings release provides context for market activity on Pluang as of Oct 06, 2026 18:51 WIB. On this day, 119 of 150 US stocks traded on Pluang rose, while 24 fell. AstraZeneca (AZN) led with a 2.01% increase and a strong 95% buy order activity, contrasting with Advanced Micro Devices (AMD) which had a slightly lower 1.92% gain and a higher 31% sell order activity, while United Airlines (UAL) rose 1.82% with a shorter typical hold time of 46 days compared to AZN's 126 days and AMD's 92 days.
Morgan Stanley analyst Bob Huang lowered American International Group's (AIG) price target to $80 from $81, with the stock trading around $76, indicating potential upside. AIG is set to report its Q3 2026 earnings on November 3, with investors focuse...
Vertiv Holdings, a maker of power and cooling equipment for data centers, faces mixed analyst opinions with GLJ Research rating it a "Sell" and BMO Capital giving an "Outperform" rating. Despite a recent stock pullback, the company reported a 241% in...
Apogee Enterprises reported strong fiscal Q2 results with adjusted earnings of $1.17 per share, nearly double the estimated $0.59, and revenue of $391.14 million, surpassing expectations of $362.6 million. This marks a continued trend of beating esti...
McKesson received a bullish price target of $977 from Morgan Stanley, suggesting a 6.7% upside from its current price of $915.45. The company agreed to acquire Option Care Health for $32.05 per share, valuing the deal at approximately $5.8 billion in...
Ameriprise Financial has authorized an additional $5.5 billion for share repurchases through September 2028, supported by $2.1 billion in excess capital and $2.8 billion in liquidity. The company returned $1.9 billion to shareholders in H1 2026, incl...
